GSK plc
GLAXF
$26.08
-$0.80-2.98%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 7.53B | 7.22B | 4.43B | 3.98B | 3.26B |
| Total Depreciation and Amortization | 2.75B | 3.84B | 4.08B | 3.34B | 3.00B |
| Total Amortization of Deferred Charges | 292.59M | 270.22M | 270.22M | 270.22M | 270.22M |
| Total Other Non-Cash Items | 2.14B | 2.49B | 2.02B | 1.66B | 1.50B |
| Change in Net Operating Assets | -2.44B | -3.60B | -771.03M | -617.52M | 376.04M |
| Cash from Operations | 10.27B | 10.22B | 10.03B | 8.63B | 8.40B |
| Capital Expenditure | -1.79B | -1.72B | -1.70B | -1.74B | -1.79B |
| Sale of Property, Plant, and Equipment | 31.97M | 92.80M | 87.36M | 83.20M | 83.21M |
| Cash Acquisitions | -2.23B | -2.26B | -1.10B | -1.14B | -1.05B |
| Divestitures | -35.98M | -43.72M | -48.97M | -20.40M | -22.94M |
| Other Investing Activities | -1.56B | -1.84B | -1.90B | -38.65M | 1.17B |
| Cash from Investing | -5.58B | -5.77B | -4.66B | -2.85B | -1.60B |
| Total Debt Issued | 3.19B | 3.98B | 4.06B | 3.42B | 1.34B |
| Total Debt Repaid | -1.93B | -3.00B | -3.55B | -2.57B | -2.73B |
| Issuance of Common Stock | 15.00M | 14.00M | 15.00M | 14.00M | 20.00M |
| Repurchase of Common Stock | -1.38B | -1.13B | -808.00M | -247.00M | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -3.38B | -3.31B | -3.23B | -3.17B | -3.12B |
| Other Financing Activities | -1.02B | -1.01B | -829.00M | -936.00M | -910.00M |
| Cash from Financing | -5.00B | -4.94B | -4.78B | -3.61B | -6.03B |
| Foreign Exchange rate Adjustments | -23.56M | 39.93M | -83.87M | -59.23M | -69.46M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -336.31M | -451.89M | 503.86M | 2.11B | 698.87M |